Parkinson's Disease: Diagnostics & Clinical Trials

Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement. This feed focuses on therapeutic aspects, diagnostic tools including medical imaging, and clinical trials in PD.

January 19, 2022
Review

Levodopa-induced dyskinesia: a historical review of Parkinson's disease, dopamine, and modern advancements in research and treatment.

Journal of Neurology
Carissa A HansenHabibeh Khoshbouei
January 19, 2022

mTOR Inhibition with Sirolimus in Multiple System Atrophy: A Randomized, Double-Blind, Placebo-Controlled Futility Trial and 1-Year Biomarker Longitudinal Analysis.

Movement Disorders : Official Journal of the Movement Disorder Society
Jose-Alberto PalmaHoracio Kaufmann
January 18, 2022

The use of virtual reality to modify and personalize interior home features in Parkinson's disease.

Experimental Gerontology
Shabboo ValipoorAparna A Wagle Shukla
January 17, 2022

A brain network for deep brain stimulation induced cognitive decline in Parkinson's disease.

Brain : a Journal of Neurology
Martin M ReichMichael D Fox
January 17, 2022

Altered Cholinergic Innervation in De Novo Parkinson's Disease with and without Cognitive Impairment.

Movement Disorders : Official Journal of the Movement Disorder Society
Sygrid van der ZeeTeus van Laar
January 17, 2022

Locomotor Assessment of 6-Hydroxydopamine-induced Adult Zebrafish-based Parkinson's Disease Model.

Journal of Visualized Experiments : JoVE
Naemah Md HamzahKalavathy Ramasamy
January 17, 2022
Review

Lysosomal dysfunction in neurodegeneration: emerging concepts and methods.

Trends in Neurosciences
Vinod UdayarRavi Jagasia
January 17, 2022

Shaping plasticity with non-invasive brain stimulation in the treatment of psychiatric disorders: Present and future.

Handbook of Clinical Neurology
Mark S GeorgeMelanie Wiley
January 17, 2022

Adaptive deep brain stimulation: Retuning Parkinson's disease.

Handbook of Clinical Neurology
Nicoló G Pozzi, Ioannis U Isaias
January 17, 2022

Noninvasive neuromodulation in Parkinson's disease: Neuroplasticity implication and therapeutic perspectives.

Handbook of Clinical Neurology
Giuseppe CosentinoFabio Blandini
January 17, 2022

Parkinson's disease: Alterations of motor plasticity and motor learning.

Handbook of Clinical Neurology
Kaviraja UdupaRobert Chen
January 17, 2022

Metabolic imaging and plasticity.

Handbook of Clinical Neurology
Ji Hyun Ko, Antonio P Strafella

Sign up to follow this feed and discover related papers.

Related Feeds

3D Cellular Models of Brain and Neurodegeneration

Brain organoids are three-dimensional in vitro cellular models of the brain that can recapitulate many processes such as the neurodevelopment. In addition, these organoids can be combined with other cell types, such as neurons and astrocytes to study their interactions in assembloids. Disease processes can also be modeled by induced pluripotent stem cell-derived organoids and assembloids from patients with neurodegenerative disorders. Discover the latest research on the models here.

AFM in situ DNA

AFM in situ DNA describes in situ analysis (or study) of DNA using atomic force microscopy. Discover the latest research on AFM in situ DNA here.

ALS & FTD: TDP-43

TAR DNA-binding protein 43 (TDP-43) is a pathological protein identified in sporadic Amyotrophic Lateral Sclerosis (ALS) and Frontotemporal Dementia (FTD). Here are the latest discoveries pertaining to TDP-43 and these diseases.

ALS: Genetics

Amyotrophic Lateral Sclerosis (ALS) is a progressive neurodegenerative disorder characterized by muscle weakness. ALS is a genetically heterogeneous disorder with several causative genes. Here are the latest discoveries pertaining to the genetics of this disease.

ALS: Pathogenic Mechanisms

Amyotrophic Lateral Sclerosis is a progressive neurodegenerative disorder characterized by muscle weakness. Here is the latest research investigating pathogenic mechanisms that underlie this genetically heterogeneous disorder.

ALS: Phenotypes

Amyotrophic Lateral Sclerosis (ALS) is a neurodegenerative disorder characterized phenotypically by progressive muscle weakness. Clinical phenotypes of ALS can be classified based on the pattern, level, and area of onset (e.g. bulbar, cervical, lumbar). Here is the latest research investigating phenotypes of ALS.

ALS: Prions

Prions are misfolded proteins which characterize several fatal neurodegenerative diseases. Prion-like mechanisms are associated with the pathogenesis of Amyotrophic Lateral Sclerosis (ALS). Here is the latest research on ALS and prions.

ALS: Stress Granules

Amyotrophic Lateral Sclerosis (ALS) is a neurodegenerative disease characterized by cytoplasmic protein aggregates within motor neurons. TDP-43 is an ALS-linked protein that is known to regulate splicing and storage of specific mRNAs into stress granules, which have been implicated in formation of ALS protein aggregates. Here is the latest research in this field.

ALS: Therapies

Amyotrophic Lateral Sclerosis (ALS) is associated with the death of neurons that control voluntary muscles. This feed followes the latest research into therapies for this progressive neurodegenerative disease.

Age-related Dementia

Dementias are a group of conditions, including Alzheimer's disease, vascular dementia, and frontotemporal dementia, characterized by deficiencies in cognitive abilities. Age-related dementia refers to dementias that occur in older individuals, usually 60+ years old, in contrast to early-onset dementia. Follow the latest research on age-related dementia here.

© 2022 Meta ULC. All rights reserved
/feed-previews/parkinsons-disease-diagnostics-and-clinical/6034e3fd-2763-4cbc-860f-f5877e3d6425